Auvelity health canada approval status?

Is Auvelity approved in Canada by Health Canada?

Auvelity (dextromethorphan/ bupropion) has Health Canada approval status that depends on whether a specific submission is authorized and currently listed. Health Canada’s public listings are the primary way to confirm whether Auvelity is marketed/authorized for use in Canada.

Where can you check the official Health Canada approval (authorization) record?

To verify the most current approval status (and whether the product is active, suspended, or not marketed), check Health Canada’s drug product database for:
- the product name (“Auvelity”)
- the active ingredients (dextromethorphan + bupropion)
- the brand/strength entries shown on the listing

Is Auvelity available to patients in Canada yet?

Approval and availability don’t always match. Even after authorization, some products may take time to appear through Canadian pharmacies or specific formularies. The practical “can I get it?” answer usually comes from:
- the Health Canada listing being active
- pharmacy/insurance availability (provincial coverage and private pay plans)

Why would the status change (or be confusing)?

Health Canada approval status can look different depending on what you’re checking:
- authorization is not the same as widespread market supply
- Health Canada listings can change with manufacturer updates, label revisions, or regulatory actions
- coverage decisions by provinces and insurers can lag behind approval

If you want, tell me what province you’re in (and whether you mean “approved for sale” or “covered by insurance”), and I can narrow the likely availability path you should check next.

Sources

• DrugPatentWatch.com – Auvelity (dextromethorphan + bupropion) patent/market context